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Chronic progressive renal lesions induced by lithium. New Zealand
white rabbits, eight fed lithium (Li) (50 to 250 minole LiCI/kg food) and
seven controls (C) had sequential open renal biopsies at zero, one,
three, six, and 12 months. A distinctive histological lesion, consisting of
cytoplasmic vacuolation and accumulation of glycogen in cells lining
distal convoluted tubules and collecting ducts, was present in Li (one,
three, six, and 12 months), but was absent in Li prior to lithium (zero
months) and in C (zero, one, three, six, and 12 months). Histological
changes of chronic focal interstitial nephropathy namely, interstitial
fibrosis, (quantitated by point counting), tubular atrophy and cast
formation (quantitated by digitization), and glomerular sclerosis (deter-
mined as the percent of sclerosed glomeruli) showed significant differ-
ences between Li and C from as early as one month (interstitial fibrosis,
P < 0.02; tubular atrophy, P < 0.05; casts, P <0.05), and up to 12
months (glomerular sclerosis, P < 0.05). Distal tubular dilatation and
microcyst formation, (quantitated by digitization) was also marked in Li
compared with C from one month (P < 0.05). The degree of distal
tubular dilatation and other changes of interstitial nephropathy tended
to progress with duration of lithium exposure. Macroscopically, Li
kidneys (12 months) were pale, granular, and exhibited microcysts.
Raised blood urea (P < 0.02) and serum creatinine levels (P < 0.05)
were also late features (12 months) of lithium—induced nephropathy.
The data support the view that lithium induces chronic renal lesions.
The precise relationship between the distinctive distal tubular lesion,
distal tubular dilatation and focal interstitial nephropathy remains
speculative.
Lithium salts are widely used for the treatment of severe
affective disorders. Estimates [1—3] suggest that one per 1000 of
the human population is taking lithium, and reports of chronic
renal damage (focal interstitial nephropathy) occurring in up to
26% of patients on lithium [4—8] created concern among
nephrologists and psychiatrists.
We reported a specific lesion of the distal tubules and
collecting ducts in patients taking lithium [9, 10]. This consisted
of swelling and vacuolization of tubular cells with the prominent
accumulation of glycogen granules in the cytoplasm. Such
lesions were associated with areas of fibrosis, dilated tubules,
cast formation and desquamation of tubular cells, which sug-
gested that these acute lesions may be precursors of the
reported chronic focal interstitial nephropathy. Desquamated
tubular cells and casts could cause individual tubular obstruc-
tion, cyst formation and focal nephron atrophy.
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Several studies in rats [11—13] have demonstrated dilatation
of tubules but not loss of renal parenchyma. This tubular
dilatation only occurred in rats which developed diabetes
insipidus, suggesting that the tubular dilatation might merely
reflect the polyuria seen in rats on lithium [14, 15]. In a 60 week
unpublished study in rats, we were unable to document pro-
gressive damage or interstitial fibrosis [16] nor have such
changes been unequivocally documented by others [11—13].
Rats did not develop the acute lesion which we describe in
humans [9, 10] nor has this lesion been observed by others
[11—13, 17—24].
In normal adult rats the collecting ducts do not contain
glycogen, whereas this is present in the rabbit [25—27]. On this
basis we postulated that the rabbit may prove a more suitable
model than the rat for studies of lithium nephrotoxicity. On the
assumption that chronic damage may be related to glycogen
accumulation in distal tubular cells we have carried out a long
term study in rabbits.
Methods
Animals and procedures
Fifteen New Zealand white rabbits, eight treated with lithium
chloride, 50 to 250 mmole LiC1/kg dry weight of food (Li), and
seven controls (C) were observed over 12 months. The amount
of lithium chloride added to the food was adjusted to maintain
serum lithium levels above 1.5 mmole/l (Results). Animals were
housed in individual cages with free access to water and
received a standard diet (Barastoc Rabbit and Guinea Pig
Ration, Barastoc Products, KMM Pty. Ltd., Melbourne, Aus-
tralia) supplemented with lettuce.
Animals were weighed once every two weeks. Blood was
obtained at zero, six, and twelve months for serum creatinine
and blood urea, and at two to four weekly intervals for serum
lithium estimation. Twenty-four hour urine samples were col-
lected in a metabolic cage at zero, three, six, and 12 months.
Renal biopsies
Renal biopsies were taken through a midline abdominal
incision under general anaesthesia (induction: alphaxolone 6 to
10 mg/kg i.v.; maintenance: N2O:O2, 2:1 and alphaxolone ito 5
mg/kg supplements) at zero, one, three, six, and 12 months.
Sequential biopsies were taken from the left upper pole, left
lower pole, right upper pole, right lower pole and left lateral
border respectively, to eliminate any effects of previous surgery
on histological interpretation. Biopsy tissue size was approxi-
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mately 1 mm (width) x 10 mm (length) x 5 mm (depth). At 12
months animals were sacrificed, and the whole kidneys were
removed and weighed.
The tissue was fixed in mercuric formalin (10%) and sections
I to 2 rm were stained with hematoxylin and eosin, periodic
acid Schiff(PAS), Masson's trichrome, and silver methenamine
counter stained with Masson's trichrome. Additional PAS
staining was performed after pre-treatment of the biopsy spec-
imens with diastase.
Because of the presence of a specific lesion in the distal
tubules and collecting ducts (Results), two additional rabbits
were fed LiCI, 50 to 150 mmole/kgldry weight of food for one
month. These two animals had open renal biopsies initially,
then at one month and two weeks after discontinuing lithium
supplementation.
Assessment of renal histology
Macroscopic. The kidneys were examined macroscopically
and a qualitative assessment of renal damage carried out at 12
months. The immersion fixed weight of each kidney was
determined and the mean of the two kidneys for each animal
recorded.
Microscopic. A qualitative assessment of histological sec-
tions examined at magnifications of x25 to x 1000 was carried
out.
Quantitative assessment of the non-specific histological
changes; interstitial fibrosis, tubular atrophy, casts, glomerular
sclerosis and dilatation of the distal convoluted tubules and
collecting ducts, including microcyst formation (distal tubular
dilatation), was carried out under light microscopy.
Interstitial fibrosis was estimated by determining the percent
of interstitial fibrosis by a point counting technique 128, 29].
Single stained (Masson's trichrome) sections of renal cortex
were exnmined under light microscopy (magnification x400)
using a wide—angle eye—piece and a 121—point (100 square)
eye—piece micrometer. The distance between points was 10
mm. Between three and seven representative sections of the
renal cortex were analyzed (percent of interstitial fibrosis =
number of points overlying renal cortical interstitium as a
percentage of total points counted). Glomeruli and large vessels
were deliberately avoided. Where sections showed areas of
focal fibrosis, relatively more sections were counted.
Tubular atrophy and cast formation were determined from
the area of renal cortex measured on a single stained (silver
methanine counterstained and Masson's trichrome) section
examined under low magnification (x40). Using a microscope
extension eye—piece, the image of the cursor of a digitizer
(Hewlett Packard 9874, Hewlett Packard, Elkhart, Indiana,
USA) attached to a pre-programmed calculator (Hewlett
Packard 9825A) was superimposed on the section under micros-
copy and the area of renal cortex was determined by digitiza-
tion. The total number of atrophic tubules and the total number
of casts were counted in the same section. The ratio of the total
number of atrophic tubules or casts to the area of renal cortex
was recorded.
To determine distal tubular dilatation, between 15 and 25
distal convoluted tubules and/or cortical collecting ducts (cut in
a relatively straight cross section and selected at random) on a
single stained (Masson's trichrome) section of renal cortex
examined under light microscopy (magnification x 200) were
Table 1. Animal body weights, median values (range).
Months
C
Weight, kg N
Li
Weight, kg N P value
0 2.3 (1.6—3.2) 7 2.3 (1.6—2.6) 8 NS
1 2.7 (2.1—3.5) 7 2,4 (1.9—2.5) 8 <0.05
3 3.2 (2.4—3.9) 7 2.4 (1.9—2.7) 8 <0.05
6 3.5 (2.6—4.0) 6 2.4 (2.2—3.3) 6 <0.05
12 3.9 (2.6—3.6) 5 2.6 (2.2—3.2) 6 <0.05
Abbreviations are: N, number of rabbits; NS, not significant.
digitized to determine the area of each lumen. The median value
and range of values of the luminal distal nephron areas deter-
mined for each biopsy specimen were recorded.
Statistics. The comparisons of results for various determina-
tions between Li and C were carried out using the Mann
Whitney rank sum test. P <0.05 was taken as significant.
Results
Animals
Although Li animals gained weight relatively poorly (Table 1)
compared with C, the prolonged administration of lithium
chloride was generally well tolerated.
The optimal concentration of lithium in the food proved to be
100 to 150 mmole LiClIkg food, and this dosage was maintained
in all Li animals for >90% of the experiment. Serum lithium
levels in Li animals over the period of study were always >0.50
mmole/l and only nine of 136 (6.6%) observed values were
>2.50 mmole/l. Median estimations of serum lithium levels for
the Li animals from one month onwards were >1.00 mmole/l
and <2.00 mmole/l. On nine occasions in five Li animals,
lithium supplementation was withdrawn for 24 to 72 hours
because of loss of weight, loss of appetite and decreased
spontaneous activities.
Two Li animals probably developed acute lithium toxicity in
relation to respiratory illnesses and died one week and two
weeks prior to the three month assessment. One of these rabbits
also had impaired renal function (serum creatinine 0.39
mmole/l). One C animal died 24 hours after the anesthetic for
the open renal biopsy at the three month evaluation. One other
C animal died at nine months. Post-mortem revealed a tubo-
ovarian abscess. Animal deaths meant that only 11 rabbits were
available for full histological evaluation at 12 months.
Renal histology
Macroscopic. The macroscopic appearances of the whole
kidney specimens removed at 12 months were very striking.
Animals exposed to lithium had pale granular kidneys with
obvious fibrosis seen macroscopically (Fig. 1). The kidneys
were difficult to cut, but the cut surfaces revealed a granular
appearance similar to the capsular surface. There were
microcysts (up to 1.0 mm in diameter) evident on the capsular
and cut surfaces of Li kidneys. One C animal had an old blood
clot in the pelvis of the right kidney, presumably the result of
biopsy, and the kidney was markedly reduced in size. No
further assessment was carried out on this kidney. Li animals
appeared to have increased medullary zones and decreased
cortical zones compared to C. The enlargement of medullary
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Fig. 2. Cortical collecting duct of a rabbit on lithium—supplemented diet
for one month showing epithelial lining cells with variable degrees of
vacuolation and accumulation of PA S—positive granular material (gly-
cogen), particularly at the luminal border of the cell. PAS x630 (oil).
Fig. 1. Macroscopic appearance of kidneys from rabbit on lithium
supplementation for 12 months (top). Cut surface (saggital) on right;
capsular surface on left. Macroscopic appearances of kidneys from a
control animal at 12 months (bottom). Note relatively smooth appear-
ances. Scars in polar regions are due to previous open biopsies.
zones seemed to be explained largely by an increase in the outer
medullary zone region (Fig. 1). The enlargement of medullary
zones was even more impressive in relation to the body weights
of the animals.
The median (range) of the immersion fixed weights (mean of
the two kidneys from each animal) were not different between
Li, 9.3 (7.5 to 11.6 g) and C, 9.5 (6.7 to 10.5 g).
Microscopic, qualitative
Lesion in distal convoluted tubules and collecting ducts. In
all Li biopsies and in no C biopsies, a distinctive lesion of the
distal tubules identical to that seen in biopsies from patients
taking lithium was observed (Fig. 2). This lesion occurred in
distal convoluted tubules, but was particularly marked in cor-
tical collecting ducts. The epithelial cells lining affected distal
nephron segments were vacuolated, swollen and showed
PAS—positive material in strands and granules throughout the
cytoplasm, particularly at the periphery of the cells, and par-
ticularly on the luminal side of the cell (Fig. 2). Similar granules
were also present in the lumen. The PAS—positive granules
Fig. 3. Section of renal cortex of biopsy from animal on lithium
supplementation for 12 months. Apart from extensive interstitial fi-
brosis and atrophic tubules, note gross dilatation of some distal tubules
(microcysts) containing amorphous casts. (Masson trichrome, X 126).
proved to be glycogen because they disappeared when sections
were pre-treated with diastase. The lesion was also identified on
the biopsies (one month) of the two additional rabbits given
lithium, and the fact that the lesion was related to lithium was
further suggested by its disappearance in two rabbits in biopsies
done two weeks after stopping lithium.
Non-specific chronic histological changes. Interstitial fibro-
sis, tubular atrophy and cast formation were observed in nearly
all biopsies. Such lesions were particularly prominent in the Li
animals and appeared to progress with the duration of lithium
administration. Cast formation was very evident in the two
rabbits which died of apparent acute lithium toxicity. Scierosed
glomeruli were difficult to detect except on silver stains. On
other stains they became incorporated into the interstitial
fibrosis. Glomerular sclerosis tended to be a late feature of the
Li biopsies. Interstitial cellular infiltration with mononuclear
cells was prominent in only one biopsy from a Li animal at one
month.
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Dilatation of distal convoluted tubules/collecting ducts and
microcyst formation. Biopsies from Li showed gross dilatation
of cortical collecting ducts (Fig. 3). Dilated tubules frequently
contained PAS—positive casts and the epithelial lining was
flattened. Some were sufficiently dilated to constitute
microcysts. Cells lining dilated tubules frequently showed the
specific lithium associated lesion referred to above. Mitoses
were also frequently observed in distal convoluted tubules and
cortical collecting ducts.
Microscopic, quantitative
The details of quantitative assessment of interstitial fibrosis,
tubular atrophy, casts and glomerular sclerosis are shown in
Figure 4. Significant differences between Li and C could be
observed for all of these changes. The severity of these changes
appeared to be progressive with duration of lithium therapy,
although any comparison between the quantitative assessment
at six, 12 months, and the other intervals was made difficult by
the death of four animals during the period of observation.
The results of the quantitative assessment of distal tubular
dilatation (distal nephron luminal areas) is shown in Table 3. The
presence of this distal tubular dilatation was clearly more promi-
nent in Li treated animals compared to C. Because of the wide
variation in tubular luminal size, an analysis of median values and
range of tubular luminal areas was carried out. The presence of
distal tubular dilatation was apparent in Li at one month and
progressed with duration of lithium therapy (Table 3).
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Fig. 4. Quantitative assessments of interstitial fibrosis, tubular atrophy, casts and glomerular sclerosis as determined on renal biopsies at 0, 1, 3,
6, and 12 months. Symbols are: S, lithium—fed rabbits; 0, control rabbits.
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Table 2. P values for lithium-fed vs. control rabbits
Months
0 1 3 6 12
Interstitial fibrosis
Tubular atrophy
Casts
Glomerular sclerosis
NS
NS
NS
NS
<0.02
<0.05
<0.02
NS
<0.01
<0.05
<0.01
NS
<0.01
<0.05
<0.01
NS
<0.02
<0.02
<0.02
<0.05
Abbreviation: NS, not significant.
Table 3. Distal tubular dilatation, median values (range).
Months
C
Median,
mm2 X JO-I N
Li
Median,
nun2 X iO N P value
0
1
3
6
12
0.7 (0.6—0.8)
0.7 (0.6—0.8)
0.7 (0.6—0.8)
0.8 (0.6—1.1)
0.7 (0.7—1.1)
7
7
7
6
5
0.7 (0.6—1.0)
1.1 (0.6—1.1)
1.2 (0.6—1.7)
1.2 (1.0—3.0)
1.8 (1.2—2.2)
8
8
8
6
6
NS
<0.05
<0.01
<0.02
<0.02
Range, mm2 X iO Range, mm2 X JO
0
1
3
6
12
1.0 (0.7—1.5)
1.0(0.8—1.4)
1.1 (0.6—1.4)
1.4 (0.6—2.3)
1.4 (0.8—1.7)
7
7
7
6
5
1.8 (0.8—9.9)
1.8(0.8—9.9)
4.0 (2.1—8.5)
6.6 (3.9—24.8)
17.9 (3.7—30.8)
8
8
8
6
6
<0.01
<0.05
<0.01
<0.01
<0.02
Abbreviations are: NS, not significant; N, number of rabbits.
Renal function
The results of determination of serum creatinine and blood
urea are shown in Table 4. Renal impairment was a late feature
of lithium—induced nephropathy when interstitial fibrosis (Fig.
3) was extensive. Li animals were polyuric compared with C
(Table 4) although the degree of polyuria in Li animals did not
appear to progress after the first month.
Discussion
It is known that very young rodents show glycogen in the
collecting ducts of the kidney but this glycogen tends to
disappear in adulthood [25]. In normal adult rabbits however,
glycogen reserves are found in the collecting duct epitheium
[26] but this glycogen content varies under differing physiolog-
ical states in response to the energy requirements of the cell
[25—27]. It is suggested that cyclic AMP produced by the action
of vasopressin—sensitive adenyl cyclase acts as a 'switch effect'
on glycogen metabolism [27]. During hydropenia (dehydration),
increased intracellular cyclic AMP concentrations occur sec-
ondary to high vasopressin levels, and this leads to increased
glycogen breakdown and decreased glycogen synthesis. Con-
versely, during water loading when the energy requirements of
distal nephron cells are diminished, low vasopressin levels and
consequently low cyclic AMP levels lead to an accumulation of
glycogen [271.
Lithium administration is known to significantly inhibit the
adenyl cyclase activity response to vasopressin in distal tubules
[30]. It also directly inhibits a number of enzymes involved in
glycogen breakdown [31]. These effects favour the accumula-
tion of glycogen. In the distal tubule of the kidney in man,
where lithium levels may be very high [32], the accumulation of
glycogen was anticipated [10], even though during lithium
therapy, volume depletion (dehydration) and consequent high
levels of vasopressin often co-exist [33]. A similar mechanism
may occur in rabbits fed lithium.
The lesion of the distal tubule observed in rabbits was
strikingly similar to the lesion identified in humans on mainte-
nance lithium therapy [9, 10]. How the presence of such a lesion
might predispose such cells to chronic damage remains
undetermined.
More important than the observation of the acute lesion
associated with glycogen accumulation is the chronic damage
which occurred in rabbits, and which contrasts strikingly with
our own findings in rats [16] and with the relatively minor
tubular changes described by others in the rat [11—13, 17—24].
The lesions in rabbits, in particular the dilated tubules and focal
interstitial fibrosis (Fig. 3), are very like the lesion originally
described by Hestbech and colleagues [4—6] and subsequently
observed in our own human studies [9, 10, 34-36].
Although renal biopsies in studies in humans with affective
illness showed abnormalities in biopsies taken before lithium
was administered [34—36], the dilated tubules were significantly
increased in biopsies from patients on lithium compared with
the pre-lithium group [35]. In rat studies, even in the absence of
significant interstitial nephropathy, dilated tubular change has
been suggested to be due to lithium administration [11—13, 24]
and not just a consequence of lithium—induced polyuria. In one
of the few studies controlled for polyuria [37], dilated tubular
change and other features of cellular proliferation were more
apparent in lithium—treated animals than in Brattleboro and
glucose—treated rats with comparable degrees of polyuria. The
dilated tubular change in this rabbit study also seems likely to
be only partly explained by polyuria. The degree of distal
tubular dilatation was progressive with the duration of therapy,
while the degree of polyuria remained unaltered after the first
month. Polyuria would not seem to explain the development of
the progressive morphological damage with features of a
chronic interstitial nephropathy.
Apart from the possible influence of polyuria, the pathogen-
esis of the dilated tubular change and interstitial nephropathy
remains obscure. In humans, the presence of PAS—positive
casts and desquamated tubular cells in lumens of some dilated
distal nephron segments suggested individual nephron obstruc-
tion [34—36], and distal tubular cell swelling and tubular obstruc-
tion has also been suggested as a mechanism by Hansen [38].
However, experimental studies in rats [24, 371 suggest that
lithium—induced cellular proliferation is associated with a pre-
carious state in distal tubular cell turnover which makes such
cells sensitive to injury and predisposes the kidney to the
development of interstitial nephritis [37].
Lithium therapy in man may also be associated with a
kaliuresis, but this is usually a transient phenomena [39, 40],
and hypokalemia has not been a major observation in long—term
clinical studies [41]. In animal studies, however, potassium
supplementation protects against lithium—induced polyuria, and
growth retardation and has also been shown to reduce distal
tubular dilatation [12, 42, 43], although potassium depletion has
not specifically been proposed as the cause of lithium—induced
interstitial nephropathy. Similarly hypercalcemia has also been
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Table 4. Lithium study: renal function and urine voluem, median values (range).
C
Serum creatinine,
Li
PSerum creatinine,
Months mmole/liter N mmole/liter N value
0 0.08 (0.07—0.10) 7 0.09 (0.07—0.10) 8 NS
6 0.10 (0,08—0.11) 6 0.10 (0.08—0.11) 6 NS
12 0.09 (0.08—0.14) 5 0.20 (0.11—0.58) 6 <0.05
0
Blood urea, mmole/liter Blood urea, mmole/liter
NS6.6 (3.4—7.6) 7 6.9 (4.7—8.4) 8
6 6.0 (4.8—7.8) 6 6.6 (6.1—8.6) 6 NS
12 6.8 (6.2—9.2) 5 13.4 (8.9—35.8) 6 <0.02
0
Urine volume, ml/24 hr Urine volume, ml/24 hr
NS81 (44—206) 7 127 (66—217) 8
1 140 (35—258) 7 244 (62-448) 8 NS
3 78 (35—180) 7 262 (115—445) 6 <0.05
6 43 (32—129) 6 330 (260—571) 6 <0.01
12 49 (37—160) 5 277 (250—393) 6 <0.02
Abbreviations are: NS, not significant; N, number of rabbits.
a recognized, although relatively uncommon, association of
stable long—term lithium therapy in man [44, 45], and prolonged
experimental hypercalcemia may cause interstitial nephropathy
[46]. Any disturbance in potassium or calcium balance induced
by lithium and/or their possible influence on the underlying
pathological findings were not specifically examined in this
study.
The serum lithium levels recorded in this study generally
exceeded the recommended therapeutic range [0.4—1.2 mmole/l)
in man, yet there were only two animal deaths attributable to
acute lithium toxicity, and nine other minor episodes in which
five Li animals required temporary discontinuation of the
lithium supplementation. The therapeutic index of lithium is
very low and episodes of acute lithium toxicity have been
shown to correlate with a reduced GFR in man [47].
This animal study shows that prolonged lithium administra-
tion with or without overt episodes of acute toxicity can cause
progressive renal damage. Perhaps the most important aspect of
these findings is the extent of the morphological damage and the
fact that it is detected as early as one month after lithium
administration. It increases in extent between one month and
twelve months when a rise in blood urea and serum creatinine
levels is first apparent. In the original report by Hestbech et al
of lithium—induced nephropathy in man [61, severe histological
changes were also noted, while the glomerular filtration rate
was relatively well preserved. Although the correlation be-
tween interstitial fibrosis and glomerular fitlration rate is recog-
nized in a variety of renal disease [48, 49, 50], including
interstitial nephropathy [511, it has been suggested that as the
nephropathy develops there is a gradual loss of renal reserve
capacity, but it is only when fibrosis is very extensive that a
significant reduction in glomerular filtration rate is observed
[48, 52]. Such a pattern of damage would be consistent with the
findings in this rabbit study.
We conclude that long—term lithium administration to rabbits
caused progressive renal impairment and renal histological
change. The pathological features are strikingly similar to those
observed in humans with so—called "lithium nephropathy".
The pathogenesis of the renal damage remains obscure.
Reprint requests to Dr. Rowan G. Walker, Department of Neph-
rology, The Royal Melbourne Hospital, Parkville, 3050, Victoria,
Australia
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